Use access key #2 to skip to page content.
$50.38 0.11 (0.22%)
7/8/2008 4:00 PM

Amgen, Inc. (AMGN)

CAPS Rating:
****

A biotechnology company whcih discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

View All Commentary (AMGN)

Recs

0

Avatar satur9nine (< 20) Submitted: 5/09/08 2:07 AM : Outperform Start Price: $41.67 AMGN Score: 28.99

Plenty of drugs in the pipeline, it may be many years before this pays off.

Report this Post Replies: 0 | Reply

Featured Broker Partners